Bhavana Pothuri
@BPothuri
Followers
1K
Following
974
Media
127
Statuses
1K
Gynecologic Oncologist, parent, advocate for patients with Gyn cancer. Opinions are mine not NYU Langone School of Medicine
Joined March 2013
Congratulations to our latest @the_asci inductees from @nyulangone!!
Congratulations to Dr. Jonathan Newman & @MichaelPacold on being elected to the American Society for Clinical Investigation (#ASCI) this year! @the_asci @NYUCVDPrevent @NYULH_RadOnc
2
1
14
Congrats Anirban! @Perlmutter_CC is in great hands! Excited to work with you!
We’re excited to announce that Anirban Maitra, MD (@Aiims1742)—a pre-eminent physician-scientist whose work has widely influenced the field of pancreatic cancer research—has been appointed the new director of @Perlmutter_CC here at NYU Langone. For more: https://t.co/a710zOE04c
1
0
2
Congrats Ramez! So well deserved!
The GOG Foundation is proud to recognize Dr. Eskander for his outstanding accomplishments. For more information regarding this appointment, please see the link in our bio or visit: https://t.co/jcQhRZsklw
0
0
3
For more information on Abstract Submissions, click link in bio or go to https://t.co/2fAUmKHvv8.
#gynecologiconcology #GOGPartners #GOGF
0
1
1
What mediates resistance to T-DXd? Large study (n=2799) by @GeorgeSledge51 et al. suggests the relevance of baseline ABCC1 levels (efflux pump) and finds emerging mutations in NFE2L2 (activator of ABCC1) and KEAP1 (negative regulator of NFE2L2) post T-DXd. https://t.co/CRtBxs92GQ
2
46
134
Congratulations to Dafna Bar-Sagi (@BarDafna) @nyulangone @nyugrossman on her induction into the 2025 Class of Fellows for the @AcadofInventors!
The National Academy of Inventors is proud to announce the 2025 Class of Fellow inductees! This distinguished group includes 169 U.S. Fellows and 16 International Fellows, representing 127 research universities, government agencies, and non-profit institutions around the world.
0
2
6
For more information on the GOG-3133 press release, click link in bio or go to https://t.co/lwX15KdhtK. For more information about this clinical trial, click link in bio or go to https://t.co/SCPC7S1sZe.
#clinicaltrials #ovariancancer #GOGF #GOGPartners
0
2
2
🍎 Nutrition Is an Act of Care Good nutrition fuels healing, energy & strength. That’s why NOCC partners with @SavorHealth to offer Ina®, the 24/7 Intelligent Nutrition Assistant for cancer patients. Access expert guidance anytime: 🔗 https://t.co/2g2lXvVjyt
#KnowOvarian
0
1
0
We are hiring: Stem Cell Transplant/Cellular Therapy/Heme Malignancy Faculty Physicians/Director Will be at @ASH_hematology meeting and happy to meet with interested potential candidates - just contact me directly #ASH25 #ASH2025
https://t.co/A4EZOz8KJM
0
13
33
A heartfelt thank you to Dr. Ros Glasspool for your dedicated leadership as IGCS Advocacy Chair. Your efforts have amplified the voice of patients and advocates worldwide and strengthened our global advocacy network. Your impact will continue to inspire meaningful change
0
5
8
Congratulations to the Targeting Minimal Residual Disease in Ovarian Cancer TeamLab! Their recent paper is now featured in the latest issue of @CCR_AACR and it’s highlighted on the cover. Revisit our piece about the research here:
breakthroughcancer.org
New study from Break Through Cancer TeamLab unveils the power of investigational biopsies, unlocking a promising tool for real-time monitoring of glioblastoma
0
3
7
Honored to present on minimally invasive surgery for cervical cancer at #IGCS2025. A reminder of the importance to complete the ROCC Trial, @GOG #3043, to determine the role of robotic surgery for radical hysterectomy. Now open at @utswcancer & @Parkland.
0
3
6
So excited to have Hilary Hinckle speak on Emotional Intelligence (EQ) Advantage: Navigating Communication in Medicine on Tuesday Nov 11! Pls RSVP asap if attending. I’m sure you will walk away with practical knowledge-looking forward to seeing all members! @NYOB_Society
0
0
2
📢 Ph2 Rezatapopt (TP53 Y220C reactivator) in TP53 Y220C–mutant solid tumors ✅ ORR 34.0% (overall), 45.8% in #OvarianCancer ✅ Manageable safety 🔥 Promising data — further exploration warranted! #Targets25
0
2
4
To view this on demand education, click link in bio or go to https://t.co/96wXHqSVMU.
#GOGF #GOGPartners #ovariancancer
0
1
3
#ESMO25 may be over, but #cancerresearch continues! Dr. Vicky Makker presented 5-year follow-up data from the 309/KEYNOTE-775 study that confirmed the efficacy and safety of lenvatinib & pembrolizumab in advanced #endometrialcancer. @MSKCancerCenter ➡️ https://t.co/xTsc41GIsk
1
5
23
Real world data re treatments beyond checkpoint inhibitors in advanced/recurrent #emca presented at #ESMO2025. Median rwOFS 5.7 mos and median rwOS 12.5 mos- more effective tx post -IO needed! @SGO_org @IGCSociety @ASCO @Perlmutter_CC @_Shareing @GOG
1
1
26
Congrats Dr. Ray-Coquard on LY4170156- FIH ph1 FR alpha ADC in #PROC. Activity seen irrespective of FRalpha with ORR 50%! Excited for upcoming ph 3 trials in PROC and PSOC! #ESMO2025 @SGO_org @IGCSociety @GOG @Perlmutter_CC @ASCO
0
1
16
Congratulations @Dr. Kari Hacker on genomic landscape HRD sig, CCNE1amp, ERBB2 alterations in over 24k #OC pts. Co-occurrence of CCNE1+ ERBB2- need for more work re functional significance! #ESMO 2025 @SGO_org @IGCSociety @ASCO @Perlmutter_CC
0
1
3
Congratulations Dr. Hacker on CCNE1 and race in #endometrial cancer from the ECMT2 consortium data! #ESMO2025 @nyulangone @Perlmutter_CC @SGO_org @ASCO @IGCSociety @SHARECancerSupt @ECANAwomen
0
1
6